Skip to main content
Figure 4 | BMC Cancer

Figure 4

From: Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis

Figure 4

SERBP1 antibody validation by Western blot analysis of breast cell lines. The SERBP1 antibody was validated by Western blot analysis of benign (MCF12A, MCF10A) and malignant (ZR75-1, BT20, HS578T, SKBR3, MDA-MB468 and MDA-MB231) human mammary cell lines. Additionally, in line with the SERBP1 mRNA data, SERBP1 protein expression in the normal mammary cell lines was not significantly different from the SERBP1 protein expression in the malignant mammary cell lines. β-actin displayed a homogenous protein loading in the investigated cell lines.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us